Estrogen and progesterone receptors in meningiomas: Immunohistochemical (Mib-1, p53) and clinicomorphological correlations;Recettori estro-progestinici nei meningiomi: Correlazioni immunoistochimiche (Mib-1, p53) e clinicomorfologiche

Pathologica

Volumn 94, Issue 1, 2002, Pages 10-15

  Taddei, G L ^a   Caldarella, A ^a   Raspollini, M R ^a   Taddei, A ^b   Buccoliero, A M ^a  

^a Dipartimento di Patologia Umana Ed Oncologia   (Italy)

^b Sezione Chirurgia Generale e DC   (Italy)

Author keywords

Hormone receptors; Immunohistochemistry; Meningioma; Mib 1; p53

Indexed keywords

ESTROGEN RECEPTOR; KI 67 ANTIGEN; PROGESTERONE RECEPTOR; PROTEIN P53; CELL NUCLEUS ANTIGEN; NUCLEAR PROTEIN; TUMOR PROTEIN;

ARTICLE; CORRELATION ANALYSIS; IMMUNOHISTOCHEMISTRY; MENINGIOMA; ADULT; AGED; CELL DIFFERENTIATION; CELL DIVISION; CHEMISTRY; COMPARATIVE STUDY; ENZYME IMMUNOASSAY; FEMALE; HUMAN; MALE; MIDDLE AGED; PATHOLOGY;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NUCLEAR; CELL DIFFERENTIATION; CELL DIVISION; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; KI-67 ANTIGEN; MALE; MENINGEAL NEOPLASMS; MENINGIOMA; MIDDLE AGED; NEOPLASM PROTEINS; NUCLEAR PROTEINS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0036483239     PISSN: 00312983     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Karamitopoulou E, Perentes E, Tolnay M, Probst A (1998) Prognostic significance of Mib-1, p53, and bcl-2 immunoreactivity in meningiomas. Hum Pathol 29:140-145
2. Cushing H (1922) The meningiomas. The cavendish lecture. Brain 45:282
3. Lanzafame S, Trisi A, Barbagallo G et al (2000) Correlation between histological grade, Mib-1, p53, and recurrence in 69 completely resected primary intracranial meningiomas with a 6 year mean follow-up. Pathol Res Pract 196:483-488
4. Nakaguchi H, Fujimaki T, Matsuno A et al (1999) Postoperative residual tumor growth of meningioma can be predicted by Mib-1 immunoistochemistry. Cancer 85:2249-2254
5. Akeson EW, McCutcheon IE (1996) Management of benign and aggressive intracranial meningiomas. Oncology 10:747-756
6. Perry A, Scheithauer BW, Stafford SL et al (1999) "Malignancy" in Meningiomas. A clinicopathologic study of 116 patients, with grading implications. Cancer 85:2046-2056
7. Cahill DW, Bashirelahi N, Solomon LW et al (1984) Estrogen and progesterone receptors in meningiomas. J Neurosurg 60:985-993
8. Mehta D, Khatib R, Patel S (1983) Carcinoma of the breast and meningioma. Association and management. Cancer 51:1937-40
9. Di Bonito L, Giarelli G, Falconieri D et al (1993) Association of breast cancer and meningioma. Report of 12 new cases and review of the literature. Path Res Pract 189:399-404
10. Wan WL, Geller JL, Feldon SE, Sadun AA (1990) Visual loss caused by rapidly progressive intracranial meningiomas during pregnancy. Ophalmology 97:18-21
11. Blankenstein MA, Koehorst SGA, van der Kallen CJH et al (1995) Oestrogen receptor independent expresion of progestin receptors in human meningioma. A review J Steroid Biochem Molec Biol 53:361-365
12. Donnel S, Meyer GA, Donegan WL (1979) Oestrogen receptor protein in intracranial meningiomas. J Neurosug 50:499-502
13. Goffin J (1986) Estrogen and progesterone receptors in meningiomas. Clin Neurol Neurosurg 88:169-175
14. Tilzer LL, Plapp FV, Evans JP et al (1982) Steroid receptor proteins in human meningiomas. Cancer 49:633-636
15. Piantelli M, Rinelli A, Macrì E et al (1993) Type II estrogen binding sites and antiproliferative activity of quercetin in human meningiomas. Cancer 71:193-198
16. Carrol RS, Glowacka D, Dashner K, Black PM (1993) Progesterone receptor expression in meningiomas. Cancer Res 53:1312-16
17. Stojkovic RR, Jovancevic M, Santel DJ et al (1990) Sex steroid receptors in intracranial tumors. Cancer 65:1968-1970
18. Concolino G, Liccardo G, Conti C et al ( 1984) Hormones and tumours in central nervous system: steroid receptors in primary spinal cord tumours. Neurol Res 6:121-126
19. McEwen BS, Denef CJ, Gerlach JL, Plapingher L (1975) Chemical studies of the brain as a steroid hormone target tissue. In: Paff D (ed) Hormonal factors in brain function. MITT Press, Cambrige, MA, pp 599-620
20. McEwen BS, Biegon A, Davis PG et al (1982) Steroid hormones: humoral signals which alter brain cell properties and functions. Recent Prog Horm Res 38:41-92
21. Verhagen A, Go KG, Visser GM et al (1995) The presence of progesterone receptors in arachnoid granulations and in the lining of arachnoid cysts: its relevance to expression of progesterone receptors in meningiomas. Br J Neurosurg 9:47-50
22. Brentani MM, Lopes MTP, Martins VR, Plese JPP (1984) Steroid receptors in intracranial tumors. Clin Neuropharmacol 7:347-50
23. Martinez R, Morcos ML, Figueras A, Vaquera J (1984) Estrogen and progesterone receptors in intracranial tumor. Clin Neuropharmacol 7:338-342
24. Von Shoultz E, Bixo M, Bäckström T et al (1990) Sex steroids in human brain tumors and breast cancer. Cancer 65:949-952
25. Koehorst SGA, Jacobs HM, Thijssen JHH, Blankenstein MA (1993) Wild type and alternatively spliced estrogen receptor messenger in human meningioma tissue and MCF7 breast cancer cells. J Steroid Biochem Molec Biol 4:227-233
26. Horwitz KB, Koseki Y, McGuire WL (1978) Estrogen control of progesterone receptors in human breast cancer: Role of the estradiol and antiestrogen. Endocrinology 103:1742-1751
27. Fuqua SA, Fitzgerald SD, Chamnes GC et al (1991) Variant human breast tumor estrogen receptor with constitutive transcriptional activity. Cancer Res 52:105-109
28. Jacobs HM, Van Spriel AB, Koehorst SGA et al (1999) The truncated estrogen receptor alpha variant laking exon 5 is not involved in progesterone receptor expression in menongiomas. J Steroid Biochem Molec Biol 71:167-172
29. Fewings PE, Battersby RD, Timperley WR (2000) Long-term follow up of progesterone receptors status in benign meningioma: a prognostic indicator of recurrence? J Neurosurg 92:401-405
30. Hsu DW, Efird JT, Hedley-Whyte ET (1997) Progesterone and estrogen receptors in meningiomas: prognostic considerations. J Neurosurg 86:113-120
31. Tonn JC, Ott MM, Bouterfa H et al (1997) Inverse correlation of cell proliferation and expression of progesterone receptors in tumor spheroids and monolayer cultures of human meningiomas. Neurosurgery 41:1152-1159
32. Nagashima G, Aoyagi M, Wakimoto H et al (1995) Immunohistochemical detection with Ki-67 labeling indices in paraffin-embedded sections of meningiomas. Neurosurgery 37:478-482
33. Ahmed R, Soomro IN, Aziz SA, Hasan SH (1999) p53 and PCNA expression in benign, atypical and malignant meningiomas. JPMA J Pak Med Assoc 49:241-243
34. Kamei Y, Watanane M, Nakayama T et al (2000) Prognostic significance of p53 and p21WAF17CIP immunoreactivity and tumor micronecrosis for recurrence of meningiomas. J Neurooncol 46:205-213
35. Ohta M, Iwaki T, Kitamoto T et al (1994) MIB 1 staining index and scoring of histologic features in meningioma. Cancer 74:3176-3189
36. Abramovich CM, Prayson RA (1998) MIB 1 labeling indices in benign, aggressive, and malignant meningiomas: a study of 90 tumors. Hum Pathol 29:1420-1427
37. Matsuno A, Nagashima T, Matsuura R et al (1996) Correlation between Mib-1 staining index and the immunoreactivity of p53 protein in recurrent and non-recurrent meningiomas. Am J Clin Pathol 106:776-781
38. Louis DN, Scheithauer BW, Budka H et al (2000) Meningiomas. In: Kleihues P, Cavenee WK (eds) World Health Organization of the tumors. Pathology and Genetics. Tumours of the Nervous System. IARC, Lyon, pp 176-184
39. Taskin M, Lallas TA, Barber HRK, Shevchuck MM (1997) bcl-2 and p53 in endometrial adenocarcinoma. Mod Pathol 10:728-734
40. Schiffer D (1996) Brain Tumors. Biology, pathology, and clinical references. Springer-Verlag, Berlin Heidelberg New York
41. Pennella A, Ferri T, Serio G et al (2000) Meningioma atipico: un'analisi morfometrica del polimorfismo nucleare. Pathologica 92:25-31
42. Perry A, Stafford SL, Scheithucr BW et al (1998) The prognostic significance of Mib-1, p53, and flow cytometry in completely resected primary meningiomas. Cancer 82:2262-2269
43. Konstantinidou AE, Pavlopoulos PM, Patsouris E et al (1998) Expression of apoptotic and proliferative markers in meningiomas. J Pathol 186:325-330
44. Blaauw G, Blankenstein MA, Lambers SWJ (1986) Sex steroid receptors in human meningiomas. Acta Neurochir 79:42-47
45. Blankenstein MA, Blaauw G, Lambers SWJ, Mulder E (1983) Eur J Cancer Oncol 19:363-370
46. Hayward E, Whitwell H, Paul KS, Barnes DM (1984) Steroid receptors in Human Meningiomas. Clin Neuropharmacol 7:351-356
47. Markwalder TM, Markvalder RV, Zava DT (1984) Estrogen and progestin receptors in meningiomas: clinicopathological correlations. Clin Neuropharmacol 4:368-374